Browse by Section 100 Item List
HIGHLY SPECIALISED DRUGS PROGRAM (Private Hospital)
For Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Medical practitioners must seek approval to prescribe these items as pharmaceutical benefits prior to their dispensing under the PBS. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule.
Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the Pharmaceutical Benefits Scheme.
The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:
- 10% for drugs with a price ex-manufacturer of less than $40;
- $4 for drugs with a price ex-manufacturer of between $40 and $100;
- 4% for drugs with a price ex-manufacturer of between $100.01 and $1000;
- $40 for drugs with a price ex-manufacturer of greater than $1000.
Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.
- Legend
- MPMedical Practitioner
- NPNurse Practitioner
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MP | 6322R | DARBEPOETIN ALFAdarbepoetin alfa 30 microgram/0.3 mL injection, 4 x 0.3 mL syringes | 2 | 8 | 5 |
MP | 6489M | DARBEPOETIN ALFAdarbepoetin alfa 40 microgram/0.4 mL injection, 0.4 mL pen device | 8 | 8 | 5 |
MP | 6323T | DARBEPOETIN ALFAdarbepoetin alfa 40 microgram/0.4 mL injection, 4 x 0.4 mL syringes | 2 | 8 | 5 |
MP | 6320P | DARBEPOETIN ALFAdarbepoetin alfa 10 microgram/0.4 mL injection, 4 x 0.4 mL syringes | 2 | 8 | 5 |
MP | 6324W | DARBEPOETIN ALFAdarbepoetin alfa 50 microgram/0.5 mL injection, 4 x 0.5 mL syringes | 2 | 8 | 5 |
MP | 6490N | DARBEPOETIN ALFAdarbepoetin alfa 60 microgram/0.3 mL injection, 0.3 mL pen device | 8 | 8 | 5 |
MP | 6325X | DARBEPOETIN ALFAdarbepoetin alfa 60 microgram/0.3 mL injection, 4 x 0.3 mL syringes | 2 | 8 | 5 |
MP | 6492Q | DARBEPOETIN ALFAdarbepoetin alfa 100 microgram/0.5 mL injection, 0.5 mL pen device | 8 | 8 | 5 |
MP | 6326Y | DARBEPOETIN ALFAdarbepoetin alfa 100 microgram/0.5 mL injection, 4 x 0.5 mL syringes | 2 | 8 | 5 |
MP | 6493R | DARBEPOETIN ALFAdarbepoetin alfa 150 microgram/0.3 mL injection, 0.3 mL pen device | 8 | 8 | 5 |
MP | 6491P | DARBEPOETIN ALFAdarbepoetin alfa 80 microgram/0.4 mL injection, 0.4 mL pen device | 8 | 8 | 5 |
MP | 6438W | DARBEPOETIN ALFAdarbepoetin alfa 80 microgram/0.4 mL injection, 4 x 0.4 mL syringes | 2 | 8 | 5 |
MP | 6365B | DARBEPOETIN ALFAdarbepoetin alfa 150 microgram/0.3 mL injection, 4 x 0.3 mL syringes | 2 | 8 | 5 |
MP | 6488L | DARBEPOETIN ALFAdarbepoetin alfa 20 microgram/0.5 mL injection, 0.5 mL pen device | 8 | 8 | 5 |
MP | 6321Q | DARBEPOETIN ALFAdarbepoetin alfa 20 microgram/0.5 mL injection, 4 x 0.5 mL syringes | 2 | 8 | 5 |
MP | 11510T | DEFERASIROXdeferasirox 180 mg tablet, 30 | 6 | 180 | 2 |
MP | 11546Q | DEFERASIROXdeferasirox 180 mg tablet, 30 | 6 | 180 | 5 |
MP | 11557G | DEFERASIROXdeferasirox 180 mg tablet, 30 | 6 | 180 | 2 |
MP | 11496C | DEFERASIROXdeferasirox 360 mg tablet, 30 | 6 | 180 | 5 |
MP | 11511W | DEFERASIROXdeferasirox 360 mg tablet, 30 | 6 | 180 | 2 |
MP | 11547R | DEFERASIROXdeferasirox 360 mg tablet, 30 | 6 | 180 | 2 |
MP | 11545P | DEFERASIROXdeferasirox 90 mg tablet, 30 | 6 | 180 | 5 |
MP | 11548T | DEFERASIROXdeferasirox 90 mg tablet, 30 | 6 | 180 | 2 |
MP | 11558H | DEFERASIROXdeferasirox 90 mg tablet, 30 | 6 | 180 | 2 |
MP | 11236J | DEFERASIROXdeferasirox 125 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 11241P | DEFERASIROXdeferasirox 125 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 6499C | DEFERASIROXdeferasirox 125 mg dispersible tablet, 28 | 6 | 168 | 5 |
MP | 11238L | DEFERASIROXdeferasirox 250 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 11244T | DEFERASIROXdeferasirox 250 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 6500D | DEFERASIROXdeferasirox 250 mg dispersible tablet, 28 | 6 | 168 | 5 |
MP | 11232E | DEFERASIROXdeferasirox 500 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 11243R | DEFERASIROXdeferasirox 500 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 9600G | DEFERASIROXdeferasirox 500 mg dispersible tablet, 28 | 6 | 168 | 5 |
MP | 9638G | DEFERIPRONEdeferiprone 100 mg/mL oral liquid, 250 mL | 5 | 5 | 5 |
MP | 6416Q | DEFERIPRONEdeferiprone 500 mg tablet, 100 | 3 | 300 | 5 |
MP | 11724C | DEFERIPRONEdeferiprone 1 g tablet, 50 | 6 | 300 | 5 |
MP | 6270B | DESFERRIOXAMINEdesferrioxamine mesilate 2 g injection, 1 vial | 60 | 60 | 5 |
MP | 6113R | DESFERRIOXAMINEdesferrioxamine mesilate 500 mg injection, 10 vials | 40 | 400 | 5 |
MP | 6120D | DORNASE ALFAdornase alfa 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | 2 | 60 | 5 |
MPNP | 6249X | DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL)doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial | 4 | 4 | 5 |
MP | 12313C | DUPILUMABdupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | 1 | 2 | 8 |
MP | 12316F | DUPILUMABdupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | 1 | 2 | 5 |
MP | 12294C | DUPILUMABdupilumab 300 mg/2 mL injection, 2 x 2 mL syringes | 1 | 2 | 5 |
MP | 12310X | DUPILUMABdupilumab 300 mg/2 mL injection, 2 x 2 mL syringes | 1 | 2 | 8 |